Canada · Federal contract register · Contract
Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $4.6M contract value ($4,635,592); No competition how it was bought (Advance Contract Award Notice: one supplier named in advance); 2024 contract date (31 July 2024).
Assay record ASY-CA-15S9YVK0LD · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · Octapharma Canada Inc.”, https://assay-systems.com/register/ca/contract/c-2025-2026-q3-03332/
| Department | National Defence |
|---|---|
| Supplier | Octapharma Canada Inc. |
| Contract date | 31 July 2024 |
| Period | 20 December 2023 – 31 March 2028 |
| Value | $4,635,592 |
| Original value | $361,523 |
| Amendments | $2,464,592 |
| Procedure | Non-competitive (Advance Contract Award Notice: one supplier named in advance) |
| Bids received | not stated |
| Economic object code | 1132 |
The department awarded it without a competition. Octapharma Canada Inc. took $4,635,592 with no other bid on the table.
Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.
Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.